
News|Articles|November 9, 2010
Nonanthracycline regimens for adjuvant treatment of operable breast cancer
Nonanthracycline-containing chemotherapy regimens for the adjuvant treatment of operable stage I to III breast cancer are discussed, including efficacy and toxicity results from recent randomized clinical trials comparing anthracycline to nonanthracycline-containing regimens.
Advertisement
Nonanthracycline-containing chemotherapy regimens for the adjuvant treatment of operable stage I to III breast cancer are discussed, including efficacy and toxicity results from recent randomized clinical trials comparing anthracycline to nonanthracycline-containing regimens.
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
7 things you need to know about the PBM reforms signed into law this week
2
A conversation about the consequences of Florida’s HIV medication cuts with Colleen Kelley, M.D., M.P.H., immediate past chair of the HIVMA and HIV specialist in Atlanta, Georgia
3
Oral Wegovy, uACR test spotlighted in the health-oriented Super Bowl ads
4
IRA price reductions to have little impact on future innovation, analysis finds
5

























